SS
RDHL

SBI Securities’s Redhill Biopharma RDHL Stock Holding History

SBI Securities’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13 Buy
15
+11
+275% +$10 ﹤0.01% 3905
2026
Q1 		$3 Hold
4
– – ﹤0.01% 3948
2025
Q4 		$4 Sell
4
-53
-93% -$71 ﹤0.01% 3948
2025
Q3 		$124 Sell
57
-1,947
-97% -$3.17K ﹤0.01% 3458
2025
Q2 		$3.89K Buy
2,004
+1,999
+39,980% +$4.07K ﹤0.01% 2109
2025
Q1 		$13 Buy
5
+3
+150% +$14 ﹤0.01% 3928
2024
Q4 		$12 Buy
+2
New +$15 ﹤0.01% 3910

Other funds holding RDHL

YAG
Yorkville Advisors Global Mountainside, New Jersey $86.2M AUM 41.28% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SAM
Smartleaf Asset Management Boston, Massachusetts $3.08B AUM 27.39% 1-Year Est. Return

SBI Securities's RDHL Position: Q2 2026 in Review

SBI Securities increased its Redhill Biopharma (RDHL) stake by 275% in Q2 2026, buying an estimated $10 and bringing the position to 15 shares worth $13. The position accounts for ﹤0.01% of the portfolio, ranked #3905.

SBI Securities first reported a position in RDHL in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.89K in Q2 2025. 14 funds tracked by Wall St. Rank hold RDHL as of Q2 2026.

  • SBI Securities held 15 shares of Redhill Biopharma worth $13 as of Q2 2026.
  • SBI Securities bought 11 Redhill Biopharma shares in Q2 2026, an estimated $10.
  • Redhill Biopharma made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3905 holding.
  • SBI Securities first reported a position in Redhill Biopharma in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Redhill Biopharma position peaked at $3.89K in Q2 2025.
  • 14 funds tracked by Wall St. Rank held Redhill Biopharma as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.